BBEU - ETF AI Analysis

Top Page

JPMorgan BetaBuilders Europe ETF (BBEU)

Rating:64Neutral

Price Target:―

BBEU, the JPMorgan BetaBuilders Europe ETF, has a solid overall rating driven by strong core holdings like HSBC, AstraZeneca, and Novartis, which all benefit from healthy financial performance, positive earnings commentary, and generally supportive valuations or growth prospects. These strengths are balanced by some holdings with valuation or technical concerns, such as SAP’s bearish momentum and potential overvaluation and Shell’s revenue and cash flow challenges, which slightly weigh on the fund’s rating. The main risk factor is its concentration in large European companies, where pockets of overvaluation and mixed technical signals could lead to periods of volatility.

Positive Factors

Low Expense Ratio

The fund charges a relatively low fee, which helps investors keep more of their returns over time.

Broad European Diversification

Holdings spread across major European markets like the UK, France, Germany, Switzerland, and others help reduce the impact of weakness in any single country.

Supportive Recent Performance

The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.

Negative Factors

Sector Concentration in Financials and Industrials

A large share of the portfolio is in financial and industrial companies, which can hurt returns if these sectors face a downturn.

Mixed Performance Among Top Holdings

While some leading positions like ASML and Siemens have been strong, others such as AstraZeneca, Nestlé, and SAP have been weak, creating uneven contribution to returns.

Limited Exposure Beyond Europe

The fund is heavily focused on European stocks with only a small allocation to the U.S., so it may not benefit as much when other global regions outperform Europe.

BBEU vs. SPDR S&P 500 ETF (SPY)

AUM9.18B

RegionEurope

Expense Ratio0.09%

Beta0.64

IssuerJPMorgan

Inception DateJun 15, 2018

Dividend Yield2.67%

Asset ClassEquity

Index TrackedMorningstar Developed Europe Target Market Exposure Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume342,952

30 Day Avg. Volume395,708

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

84.91

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering356

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

BBEU Summary

The JPMorgan BetaBuilders Europe ETF (BBEU) is a fund that aims to track the Morningstar Developed Europe Target Market Exposure Index, giving you broad access to many companies across major European markets like the UK, France, Germany, and Switzerland. It holds well-known names such as Nestlé and HSBC, along with firms in finance, industrials, health care, and technology. Someone might invest in BBEU to diversify beyond the U.S. and spread their money across many European stocks in one simple investment. A key risk is that its value can rise or fall with European stock markets and currency movements.

How much will it cost me?The JPMorgan BetaBuilders Europe ETF (BBEU) has an expense ratio of 0.09%, meaning you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks a broad European equity index, which typically involves lower costs compared to actively managed funds.

What would affect this ETF?The JPMorgan BetaBuilders Europe ETF (BBEU) could benefit from economic recovery in Europe, increased consumer spending, and advancements in technology and healthcare, as these sectors are heavily represented in its holdings. However, challenges such as rising interest rates, geopolitical tensions, or regulatory changes in Europe could negatively impact financial and industrial sectors, which are significant components of this ETF. Investors should also monitor currency fluctuations and global economic conditions, as these factors can influence the performance of European markets.

BBEU Top 10 Holdings

BBEU’s story is all about Europe’s heavy hitters, with Dutch chip-tool giant ASML doing much of the lifting as its rising share price powers the fund’s tech exposure. Health care is another key engine: Roche and Novartis have been steadily climbing, while AstraZeneca looks a bit tired after a mixed stretch. On the flip side, consumer staple Nestlé has been losing steam, and software leader SAP has been lagging, acting as a small brake. Overall, the ETF is broadly diversified across developed Europe, not dominated by any single country.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ASML	ASML Holding NV	3.97%	$363.07M	€454.71B	63.98%	76 Outperform
ROG	Roche Holding AG	2.35%	$214.96M	CHF287.83B	46.49%	73 Outperform
AZN	AstraZeneca	2.29%	$209.51M	$319.11B	29.06%	80 Outperform
NOVN	Novartis AG	2.17%	$198.38M	CHF238.17B	30.71%	80 Outperform
HSBA	HSBC Holdings	2.15%	$197.19M	£212.73B	40.54%	80 Outperform
NESN	Nestlé SA	1.91%	$175.30M	CHF201.28B	12.20%	71 Outperform
SIE	Siemens	1.64%	$150.41M	€195.89B	10.40%	74 Outperform
SHEL	Shell (UK)	1.63%	$149.29M	£162.38B	6.90%	73 Outperform
SAP	SAP SE	1.53%	$139.98M	€195.52B	-38.52%	66 Neutral
SAN	Banco Santander	1.30%	$119.20M	€147.24B	79.52%	73 Outperform

BBEU Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

74.63

Positive

100DMA

72.20

Positive

200DMA

69.24

Positive

Market Momentum

MACD

0.95

Positive

RSI

59.14

Neutral

STOCH

77.69

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BBEU, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 76.80, equal to the 50-day MA of 74.63, and equal to the 200-day MA of 69.24, indicating a bullish trend. The MACD of 0.95 indicates Positive momentum. The RSI at 59.14 is Neutral, neither overbought nor oversold. The STOCH value of 77.69 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BBEU.

BBEU Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
BBEU	―	―	$9.18B	0.09%	―
EZU	―	―	$9.83B	0.50%	―
IEUR	―	―	$7.54B	0.09%	―
FEZ	―	―	$5.32B	0.29%	―
HEDJ	―	―	$1.84B	0.58%	―
IEV	―	―	$1.74B	0.60%	―

Performance Comparison

BBEU

JPMorgan BetaBuilders Europe ETF

77.64

18.00

30.18%

EZU

iShares MSCI Eurozone ETF

―

IEUR

iShares Core MSCI Europe ETF

―

FEZ

SPDR EURO STOXX 50 ETF

―

HEDJ

WisdomTree Europe Hedged Equity Fund

―

IEV

iShares Europe ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents